Skip to main content
. 2022 Aug 30;221(10):e202201050. doi: 10.1083/jcb.202201050

Table 5.

List of primary antibodies used in this study. rb, rabbit; mo, mouse, rt, rat; WB, Western blotting; IF, immunofluorescence

Name Host Dilution WB Dilution if Reference or source
Anti-ARL13 rb 1:25–250 This study
Anti-IFT81 mo 1:1,000 (Cole et al., 1998)
Anti-IFT139 mo 1:100 (Cole et al., 1998)
Anti-IFT54 rb 1:100 (Wingfield et al., 2017)
Anti-BBS1 rb 1:500 (Xue et al., 2020)
Anti-BBS3 rb 1:2,000 (Xue et al., 2020)
Anti-BBS4 rb 1:500 (Lechtreck et al., 2009)
Anti-D1BLIC rb 1:2,000 (Hou et al., 2004)
Anti-KAP rt 1:2,000 Invitrogen, Carlsbad, CA
Anti-FMG1 mo 1:500 (Bloodgood and Salomonsky, 1994)
Anti-PKD2 rb 1:3,000 (Huang et al., 2007)
Anti-CAH6 rb 1:500 (Yu et al., 2020)
Anti-FAP12 rb 1:1,000–2,500 This study
Anti-PLD rb 1:1,000 1:80 (Lechtreck et al., 2013)
Anti-AMPK rb 1:1,000 (Liu and Lechtreck, 2018)
Anti-PLC rb 1:3,000 (Awasthi et al., 2012)
Anti-IC2 mo 1:1,000 (King and Witman, 1990)
Anti-ac tubulin 6-11B-1 mo 1:1,000 1:800 (LeDizet and Piperno, 1987); Sigma 32-2,700
Anti-GT335 mo 1:3,000 (Wolff et al., 1992); AdipoGen AG-20B-0020-C100